A randomised phase II study evaluating vismodegib as neoadjuvant treatment of basal cell carcinoma preceding Mohs micrographic surgery: results and lessons learned.

This article is protected by copyright. All rights reserved.
PMID: 30628055 [PubMed - as supplied by publisher]

Source: The British Journal of Dermatology - January 9, 2019 Category: Dermatology Authors: Soon SL, Ibrahim SF, Arron ST Tags: Br J Dermatol Source Type: research